Penn State Cancer Institute has appointed Jeffrey M. Peters, distinguished professor of molecular toxicology and carcinogenesis in the College of Agricultural Sciences and the Huck Institutes of the Life Sciences at Penn State, as its new deputy director, following a national search. As deputy director, Peters will catalyze collaborations among cancer researchers across Penn State’s colleges and campuses and help lead the Cancer Institute’s application for National Cancer Institute designation in 2018.
The PA Breast Cancer Coalition honored Nancy Lill, assistant professor of pharmacology at Penn State Cancer Institute, with a $50,000 grant to take the next steps with her research into triple-negative breast cancer.
Understanding how two genes cooperate to create an aggressive form of esophageal cancer could lead to more effective drugs to improve the cancer’s survival rate.
Alexandre Bourcier, a Penn State sophomore and Schreyer Honors Scholar, found a new way to use a cancer-treating drug during a research project in Hershey.
Hyundai Hope On Wheels and Hershey-area Hyundai dealers recently presented Penn State Children’s Hospital and Four Diamonds researcher Dr. Sinisa Dovat with a $250,000 Scholar Grant to help drive the discovery of new and improved treatments and cures for childhood cancer.
From time to time, Penn State Hershey benefits from the generosity of organizations that raise money for its programs and services. Some recent donations include the following.
T. Colin Campbell, professor emeritus at Cornell University and best-selling Author of "The China Study," gave a talk called “Nutrition Is Far More Than Meets The Eye," on Oct. 13 at the Nittany Lion Inn. Campbell appeared as part of the 2015 Penn State Forum Speaker Series.
The St. Baldrick’s Foundation, a charity that raises money for childhood cancer research, has awarded a $225,000, three-year St. Baldrick’s Scholar grant to support the work of George-Lucian Moldovan, a researcher at Penn State College of Medicine.
Pennsylvania income tax refunds can be donated to benefit cancer research in the state, including at Penn State Hershey Medical Center.
On Nov. 4, leaders from Penn State, Penn State Hershey Medical Center and the College of Medicine, along with more than 125 guests, celebrated the longstanding philanthropic partnership of Warren Gittlen and the Jake Gittlen Memorial Golf Tournament.
Penn State College of Medicine researchers have developed a nanoparticle to deliver a melanoma-fighting drug directly to the cancer. Delivering cancer drugs directly to tumors is difficult. Scientists are working on new approaches to overcome the natural limitations of drugs, including loading them into nanoparticles.
The pediatric cancer research of Penn State Hershey’s Dr. Hong-Gang Wang has received a $250,000 grant from Hyundai Hope On Wheels. The funds will support his research into whether autophagy – the human cell’s self-cleansing mechanism – can be used to make cancer cells die.
Penn State Hershey Cancer Institute is the Big Ten Cancer Research Consortium (CRC) featured member institution for the month of August. Visit www.BigTenCRC.org and click on “Featured Member” to read a Q&A with Cancer Institute Director Dr. Raymond Hohl, who explains more about Penn State Hershey’s role in the Big Ten CRC and what the Cancer Institute brings to the consortium. Penn State Hershey is one of 12 member institutions of the Big Ten CRC.
Subpopulations of breast cancer cells sometimes cooperate to aid tumor growth, according to Penn State College of Medicine researchers, who believe that understanding the relationship between cancer subpopulations could lead to new targets for cancer treatment.
Mark A. Neidig Sr., executive director of the Kanzius Cancer Research Foundation, will visit Penn State Erie, The Behrend College on Tuesday, April 8, as part of the School of Engineering’s Spring 2014 Speaker Event. The presentation is free and open to the public, and free parking will be available in the deck located behind Burke Center, off Technology Drive.